Twice-daily vs higher-dose once-daily thoracic radiotherapy for limited-disease small-cell lung cancer: A PRISMA-compliant meta-analysis

INTRODUCTION: The optimal dose and fractionation of thoracic radiotherapy (RT) for limited-disease small-cell lung cancer (LD-SCLC) remain controversial. This meta-analysis was performed to compare the efficacy and RT toxicity between twice-daily thoracic RT (45 Gy with 1.5 Gy twice daily) and highe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lin, Liu, Libo, Yang, Yanjie, Lei, Yao, Wang, Tianyi, Wu, Xiaocui, Guo, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337461/
https://www.ncbi.nlm.nih.gov/pubmed/32629632
http://dx.doi.org/10.1097/MD.0000000000020518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337461/
https://www.ncbi.nlm.nih.gov/pubmed/32629632
http://dx.doi.org/10.1097/MD.0000000000020518

Ejemplares similares